Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: September 29, 2008
On June 25, 2008, the IOM Forum on Neuroscience and Nervous System Disorders hosted more than 70 of the leading neuroscientists in the world, for a workshop titled From Molecules to Minds: Challenges for the 21st Century. The objective of the workshop was to explore a set of common goals or “Grand Challenges” posed by participants that could inspire and rally both the scientific community and the public to consider the possibilities for neuroscience in the 21st century.
Released: September 24, 2008
On December 4 and 5, 2007, the Forum on Microbial Threats hosted a public workshop in , DC to consider the possible infectious disease impacts of global climate change and extreme weather events on human, animal, and plant health, as well as their expected implications for global and national security.
Released: September 15, 2008
Design Considerations for Evaluating the Impact of PEPFAR is the summary of a 2-day workshop on methodological, policy, and practical design considerations for a future evaluation of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) interventions carried out under the President’s Emergency Plan for AIDS Relief (PEPFAR), which was convened by the Institute of Medicine (IOM) on April 30 and May 1, 2007.
Released: September 12, 2008
The National Children s Study (NCS) is planned to be the largest long-term study of environmental and genetic effects on children s health ever conducted in the United States. By archiving all of the data collected, the NCS is intended to provide a valuable resource for analyses conducted many years into the future. This report evaluates the research plan for the NCS, by assessing the scientific rigor of the study and the extent to which it is being carried out with methods, measures, and collection of data and specimens to maximize the scientific yield of the study.
Released: July 10, 2008
The Bill and Melinda Gates Foundation requested that the Institute of Medicine (IOM) conduct an independent assessment of the IPTi efficacy studies using sulfadoxine-pyrimethamine (IPTi-SP) that have been previously conducted by the IPTi Consortium. The IOM convened a committee to evaluate the evidence concerning IPTi-SP, which included addressing issues related to its utility and safety, as well as program management aspects of IPTi. The resulting letter report contains the findings, conclusions, and recommendations of the IOM committee.
Released: June 09, 2008
The use of dietary supplements has become increasingly popular among members of the military. While some supplements may provide benefits to health, others could carry adverse effects that might compromise the readiness and performance of service members. The U.S. Department of Defense, the Samueli Institute, the National Institutes of Health (NIH), with additional support from the Food and Drug Administration (FDA), requested that the Institute of Medicine (IOM) review the use of dietary supplements by military personnel, recommending a framework to identify the need for management of dietary supplement use within the military, and developing an approach to report adverse health events.
Released: May 13, 2008
Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in , DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution.
Released: April 25, 2008
Planning for an influenza pandemic, whether it occurs in the near or distant future, will need to take into account many constantly evolving factors. The Institute of Medicine (IOM) Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic was asked by the Department of Health and Human Services, (DHHS) to consider best practices and policies for providing antiviral treatment and prophylaxis during a pandemic event.
Released: March 25, 2008
The Institute of Medicine’s Food and Nutrition Board and the National Research Council’s Policy and Global Affairs Division convened a workshop in , D.C., entitled Foodborne Disease and Public Health An Iranian-U.S. Workshop.
Released: March 18, 2008
The Institute of Medicine’s Forum on Microbial Threats convened a workshop—on June 19-20, 2007, in Ft. Collins, CO—entitled Vector-Borne Diseases: Understanding the Environmental, Human Health, and Ecological Connections. The purpose of this public workshop was to examine the global burden of vector-borne diseases of humans, animals, and plants, and to discuss prospects for successful mitigation and response strategies.